Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

Background: Prediction of tumor shrinkage and pattern of treatment response following neoadjuvant endocrine therapy (NET) for estrogen receptor positive (ER+), Her2 negative (Her2–) breast cancers have had limited assessment. We examined if ultrasound (US) and Ki–67 could predict the pathologic resp...

Full description

Bibliographic Details
Main Authors: Sean C. Liebscher, Lyndsey J. Kilgore, Onalisa Winblad, Nika Gloyeske, Kelsey Larson, Christa Balanoff, Lauren Nye, Anne O’Dea, Priyanka Sharma, Bruce Kimler, Qamar Khan, Jamie Wagner
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Healthcare
Subjects:
breast cancer
neoadjuvant endocrine therapy
response to treatment
Online Access:https://www.mdpi.com/2227-9032/11/3/417

Internet

https://www.mdpi.com/2227-9032/11/3/417

Similar Items